Applied Materials invests $5 billion in India
Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.
Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.
Atlanticus Holdings (NASDAQ:ATLC) completed the sale of its CAR Auto Finance operations for approximately $71.2 million, ending the company’s Auto Finance segment.
AtlasClear Holdings (NYSE:ATCH) expects preliminary fiscal 2026 revenue of approximately $20.1 million, up about 85% from $10.9 million in fiscal 2025, according to an update from the company.
Clearmind Medicine (NASDAQ:CMND) reported that its Chief of Global Impact Mary-Elizabeth Gifford participated in a U.S. Food and Drug Administration panel focused on potential future therapeutic use of psychedelic drugs.
S&P Global (NYSE:SPGI) agreed to acquire OpenZeppelin, a provider of onchain security standards and smart contract technology, in a transaction announced September 17, 2026.
Almonty Industries (NASDAQ:ALM) entered into a long-term tungsten concentrate supply agreement with Wolfram Bergbau und Hütten AG (WBH), a subsidiary of the Sandvik Group, covering tungsten recovery from existing tailings at the Los Santos Mine in western Spain.
Bank7 Corp. (NASDAQ:BSVN) agreed to acquire 100% of Century Financial Services Corporation, the parent company of Century Bank, under a definitive merger agreement announced September 17, 2026.
Nuvation Bio (NASDAQ:NUVB) received U.S. Food and Drug Administration approval for a supplemental New Drug Application updating efficacy information for IBTROZI (taletrectinib) in TKI-naïve adults with advanced ROS1-positive non-small cell lung cancer.
Bristol Myers Squibb (NYSE:BMY) reported positive two-year results from the Phase 3 POETYK PsA-2 study and its open-label extension, showing continued efficacy and a consistent safety profile for Sotyktu (deucravacitinib) in adults with active psoriatic arthritis.
AECOM (NYSE:ACM) announced that its Board of Directors declared a quarterly cash dividend of $0.31 per share as part of its ongoing dividend program.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade